<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/e3b78ed7-b07c-46ac-ba10-4fc7cd0e188f/96BDEEEF-3AFF-42A4-9787-B28FB8C51B8F/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://www.technologyreview.com/Biotech/19623/" href="http://www.technologyreview.com/Biotech/19623/" style="font-size: 11px;">www.technologyreview.com</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.technologyreview.com/Biotech/19623/"><H1>Next-Generation Sports Doping</H1></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.technologyreview.com/Biotech/19623/"><P id="dek">New drugs in clinical trials for muscle-wasting diseases could become the next big thing for athletes. </P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.technologyreview.com/Biotech/19623/"><div align="center"><img src="http://content7.clipmarks.com/blog_cache/www.technologyreview.com/img/ACD88E8A-54F0-4801-9882-1B6764DA2FDD" alt="" /></div></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.technologyreview.com/Biotech/19623/"><table background="undefined" bgcolor=""><tr><TD class="ArticleCommentsCell"><B>Enhanced performance:</B> Olympic runner Marion Jones, shown here winning the 100 meter at the 2000 Olympics, admitted to using steroids, after years of denials. The World Anti-Doping Agency aims to prevent future abuse by tracking drugs with performance-enhancing potential while they are still in development. Credit: AP Images/Doug Mills </TD></tr></table></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.technologyreview.com/Biotech/19623/">Unlike with testosterone and other anabolic steroids, the action of SARMs and myostatin inhibitors is restricted to muscle, likely limiting side effects. That's a very good thing for patients, but it also makes the drugs more attractive to those looking to bulk up. "I think there's a whole new horizon for anabolic therapies, and the potential for abuse will be exceedingly high," says <A target="_blank" href="http://centeronaging.uams.edu/faculty/detail.asp?offset=10&ID=62">William Evans</A>, director of the Nutrition, Metabolism, and Exercise Laboratory at the University of Arkansas for Medical Sciences.</blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;">&nbsp;</td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/96BDEEEF-3AFF-42A4-9787-B28FB8C51B8F/blog/" title="blog or email this clip"><img src="http://content8.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>

New from the makers of Clipmarks:  Amplify.com - Don't just share the news...Amplify it!